@article{49d24e7d3990454fa04453ee635c3f8c,
title = "A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities",
keywords = "Schizophrenia, Depressive disorder, Antidepressive agents, Antipsychotic agents, Clinical pharmacology, Adverse effects, PSYCHIATRY WFSBP GUIDELINES, LONG-TERM TREATMENT, BIOLOGICAL TREATMENT, WORLD FEDERATION, DEPRESSIVE-DISORDERS, 5-HT2A RECEPTOR, NERVOUS-SYSTEM, UPDATE 2012, SCHIZOPHRENIA, PHARMACOLOGY",
author = "Johanna Michl and Christian Scharinger and Miriam Zauner and Siegfried Kasper and Michael Freissmuth and Sitte, {Harald H.} and Ecker, {Gerhard F.} and Lukas Pezawas",
note = "Funding Information: Funding for this study was provided by the project program grant SFB35 of the Austrian Science Fund (FWF). The FWF had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.",
year = "2014",
month = sep,
doi = "10.1016/j.euroneuro.2014.06.013",
language = "English",
volume = "24",
pages = "1463--1474",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
number = "9",
}
